Hims & Hers Health HIMS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Hims & Hers Health (HIMS) Core Market Data and Business Metrics
Latest Closing Price
$31.22Price-Earnings Ratio
58.91Total Outstanding Shares
213.79 Million SharesDividend
No dividendSIC Description
Services-offices & Clinics Of Doctors Of MedicinePrimary Exchange
New York Stock ExchangeHeadquarters
2269 Chestnut St, San Francisco, CA, 94123
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 23,751,612 Shares | 2.3 | 3/14/2025 | 54,733,233 Shares |
| 51,412,508 Shares | 1.01 | 2/28/2025 | 51,844,511 Shares |
| 20,172,156 Shares | 2.29 | 2/14/2025 | 46,122,316 Shares |
| 11,098,261 Shares | 5.24 | 1/31/2025 | 58,208,349 Shares |
| 9,648,851 Shares | 5.86 | 1/15/2025 | 56,576,887 Shares |
| 12,617,411 Shares | 4.13 | 12/31/2024 | 52,121,449 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-19.05 Million |
| Net Cash Flow From Operating Activities | $251.08 Million |
| Net Cash Flow From Financing Activities | $-107.84 Million |
| Net Cash Flow From Financing Activities, Continuing | $-107.84 Million |
| Net Cash Flow, Continuing | $124.19 Million |
| Net Cash Flow From Investing Activities, Continuing | $-19.05 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Revenues | $1.48 Billion |
| Income Tax Expense/Benefit | $-54.33 Million |
| Basic Earnings Per Share | $0.58 |
| Net Income/Loss Available To Common Stockholders, Basic | $126.04 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $125.84 Million |
| Comprehensive Income/Loss Attributable To Parent | $125.84 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-200,000 |
| Comprehensive Income/Loss | $125.84 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $707.54 Million |
| Equity | $476.72 Million |
| Other Current Assets | $315.23 Million |
| Other Non-current Assets | $268.30 Million |
| Accounts Payable | $91.18 Million |
| Current Liabilities | $221.37 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||